The UK has only one proton beam therapy facility, a small unit at the Clatterbridge Cancer Centre. The Douglas Cylotron can deliver treatment to patients with eye cancers such as choroidal melanoma. Otherwise, proton beam therapy is not available and patients who need it have to travel out of the country
The two UK centres, are located in:
A third site at the University Hospital in Birmingham may get the go-ahead soon.
The Department of Health (DoH) recognises that proton beam therapy is the best treatment for some patients with some conditions, so has set up a system to allow access to treatment in centres abroad. Since 2008, the National Specialised Commissioning Team (NSCT) has been running this system and has its own specialist clinical panel that looks at all cases individually.
To be considered for proton beam therapy you need to be referred by a consultant, who fills in a detailed referral form and submits to the NSCT panel. This group of experts then makes the final decision whether they agree that proton beam therapy is the best course of action.
If it is, they confirm this to the patient and their UK medical team and open the way for an overseas referral. The proton beam therapy takes place in one of the many international PBT centres (see below), funded by the National Health Service.
Going abroad for proton beam therapy is a big step. The treatment is done over several weeks and the patient and their family can be out of the UK for around 10 weeks. As well as the treatment costs, the NHS/NSCT also funds travel costs, accommodation during treatment and some living costs.
The UK is rather lagging behind many other countries that have built proton beam therapies in their hospitals over the last few years. More than 70,000 patients have already benefited from PBT delivered in North America, Asia and Europe.
The biggest single providers are the USA, with around 28% of all PBT centres and Japan, which has 23%. European countries are planning a rapid increase in their proton beam therapy provision in the next few years; Germany, Italy, Sweden and France are all setting up new centres.
The King Hussein Cancer Centre treats all cancers and performs approximately 300 bone marrow transplants a year. The King Hussein Cancer Centre is the one of the only specialised cancer centres in the Middle East treating both adults and children. They also offer various diagnostic imaging services such as MRI and CT scans and have a highly advanced Chemotherapy Unit.